Skip to main content
Clinical Trials/ISRCTN48527663
ISRCTN48527663
Completed
未知

Advance care planning intervention for people with multiple sclerosis: pilot and feasibility trial

Istituto Neurologico Carlo Besta0 sites38 target enrollmentMarch 30, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
People with severe progressive multiple sclerosis (pwPMS) across various health care settings in Italy
Sponsor
Istituto Neurologico Carlo Besta
Enrollment
38
Status
Completed
Last Updated
last year

Overview

Brief Summary

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34389580/ protocol (added 16/08/2021)

Registry
who.int
Start Date
March 30, 2021
End Date
February 29, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Istituto Neurologico Carlo Besta

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged \=18 years
  • 2\. Diagnosed with primary or secondary progressive multiple sclerosis from \=1 year before inclusion
  • 3\. Able to communicate in Italian
  • 4\. Gave written consent
  • 5\. Advance care plan (ACP) relevant as has \=1 of the following conditions:
  • 5\.1\. Expressed desire for ACP
  • 5\.2\. Questions about own future
  • 5\.3\. Thoughts about hastening death or medically assisted suicide
  • 5\.4\. High risk for death within two years measured using the ‘Surprise Question’
  • 5\.5\. High risk for development of severe cognitive compromise/dementia within two years

Exclusion Criteria

  • 1\. Severe cognitive compromise, a score of \<19 on the Mini\-Mental State Examination (MMSE)
  • 2\. Impairments preventing communication
  • 3\. Psychosis or other serious psychiatric conditions
  • 4\. Advance care plan (ACP) document completed

Outcomes

Primary Outcomes

Not specified

Similar Trials